Inventor · Indianapolis, IN, US

David Michael Remick

11Patents
3h-index
49Co-inventors
60Inventor score

Filing activity: Dec 13, 2002 → Sep 3, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US6730792B2 &bgr;3 adrenergic agonists Human Necessities 12 Expired
US7320994B2 Triazole derivatives as tachykinin receptor antagonists Chemistry; Metallurgy 8 Expired
US7691827B2 Amide prodrug of gemcitabine, compositions and use thereof Human Necessities 3 Active
US12102610B2 Treprostinil salt Chemistry; Metallurgy 1 Active
US11834435B2 SSTR4 agonist salts Chemistry; Metallurgy 0 Active
US8299060B2 Trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid Human Necessities 0 Active
US11820754B2 Polymorphs of an SSAO inhibitor Chemistry; Metallurgy 0 Active
US10011610B2 Selective BACE1 inhibitors Chemistry; Metallurgy 0 Active
US11926634B2 Processes for the preparation of selective estrogen receptor degraders Chemistry; Metallurgy 0 Active
US10787460B2 (E)-1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl 4-((3-isopropyl-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)amino)piperidine-1-carboxylate for inhibiting CDK7 Chemistry; Metallurgy 0 Active
US12365682B2 Process to make GLP1 RA and intermediates therefor Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.